Hims & Hers Health Inc

HIMS

Company Profile

  • Business description

    Hims & Hers, launched in 2017, is a telehealth platform that connects patients and healthcare providers to offer treatment options for specialties like erectile dysfunction, hair loss, skin care, mental health, and weight loss. Its offerings include generic, branded, and compounded prescription drugs as well as over-the-counter medicines, cosmetics, and supplements. The platform, which has more than 2 million subscribers, is available in all 50 states and certain European markets like the UK. It includes provider networks, electronic medical records, cloud pharmacy fulfillment, and personalization capabilities. Hims does not take insurance and only accepts payments directly from customers.

  • Contact

    2269 Chestnut Street
    No. 523
    San FranciscoCA94123
    USA

    T: +1 415 851-0195

    https://www.forhims.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - Specialty & Generic

    Fiscal Year End

    31 December 2026

    Employees

    2,442

Stocks News & Analysis

stocks

Global tensions drive profitability for ASX energy provider

Supply disruptions turbocharge refining profits and lift earnings forecasts for ASX energy share.
stocks

ASX energy share undervalued ahead of earnings

Pricing strength outweighs temporary production headwinds.
stocks

Tesla: Reported China divestiture plan could clear path for SpaceX merger

Media report says Tesla is exploring divestiture plans to ease regulatory approval of a Tesla-SpaceX merger.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,311.90125.801.37%
CAC 408,646.0632.240.37%
DAX 4026,219.94218.630.84%
Dow JONES (US)53,887.96709.551.33%
FTSE 10010,898.2440.540.37%
HKSE25,852.92156.48-0.60%
NASDAQ26,330.50416.601.61%
Nikkei 22563,957.53202.630.32%
NZX 50 Index13,903.46128.530.93%
S&P 5007,680.8880.381.06%
S&P/ASX 2009,145.80122.801.36%
SSE Composite Index3,822.2812.620.33%

Market Movers